Terns Pharmaceuticals (TERN) Competitor Comparison
We are evaluating the key criteria listed to compare Terns Pharmaceuticals (TERN) against its competitors in the Biotechnology industry.
Market Capitalization
171 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
195 / 337Free Cashflow
168 / 352Quick Ratio
20 / 357Earnings per Share
155 / 359Dividend yield
0 / 6Total Cash
123 / 358Performance 3 years
122 / 368Performance 5 years
197 / 368Performance 10 years
169 / 368Linearity 3 years
34 / 368Linearity 5 years
204 / 368Linearity 10 years
169 / 368Total Rank
278 / 368Dividend Rank
286 / 368Valuation Rank
53 / 368Piotroski Rank
23 / 368Muliplier Rank
217 / 368EBITDA - TERN ranking 195 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.